PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
18.34%
Revenue growth above 1.5x ADI's 5.19%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
40.10%
Gross profit growth above 1.5x ADI's 8.36%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
452.27%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
452.27%
Positive operating income growth while ADI is negative. John Neff might view this as a competitive edge in operations.
350.00%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
350.00%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
350.00%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.11%
Dividend growth of 18.11% while ADI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
30.74%
Positive OCF growth while ADI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
19.32%
Positive FCF growth while ADI is negative. John Neff would see a strong competitive edge in net cash generation.
-23.21%
Negative 10Y revenue/share CAGR while ADI stands at 125.80%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-31.88%
Negative 5Y CAGR while ADI stands at 33.24%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-23.85%
Negative 3Y CAGR while ADI stands at 11.37%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
92.96%
10Y OCF/share CAGR above 1.5x ADI's 39.55%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
-48.34%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
5.65%
Positive 3Y OCF/share CAGR while ADI is negative. John Neff might see a big short-term edge in operational efficiency.
-12.50%
Negative 10Y net income/share CAGR while ADI is at 188.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-69.24%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
-75.71%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
285.89%
10Y equity/share CAGR at 50-75% of ADI's 533.37%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
105.52%
5Y equity/share CAGR at 50-75% of ADI's 197.32%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
42.79%
3Y equity/share CAGR at 50-75% of ADI's 84.80%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
15.92%
Dividend/share CAGR of 15.92% while ADI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
6.77%
Dividend/share CAGR of 6.77% while ADI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
8.43%
3Y dividend/share CAGR of 8.43% while ADI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
22.90%
AR growth well above ADI's 12.11%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.77%
Inventory growth well above ADI's 5.00%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-3.53%
Negative asset growth while ADI invests at 0.76%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-3.98%
We have a declining book value while ADI shows 0.51%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
4.12%
We increase R&D while ADI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
11.32%
SG&A growth well above ADI's 6.85%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.